Ginkgo Bioworks (DNA) CEO Jason R. Kelly receives over 300k new RSUs

Q: What insider transactions did Ginkgo Bioworks (DNA) report for Jason R. Kelly on July 28, 2026?

Jason R. Kelly received two grants of Restricted Stock Units on July 28, 2026: one for 74,258 RSUs and another for 309,467 RSUs . Both awards are tied to Ginkgo Bioworks’ Class A Common Stock and follow specified vesting schedules.

Q: What are the vesting terms for the 74,258 RSUs granted at Ginkgo Bioworks (DNA)?

The 74,258 RSUs granted to Jason R. Kelly vest 75% on October 16, 2026 and 25% on January 21, 2027 . Once vested, each RSU entitles him to receive one share of Ginkgo Bioworks Class A Common Stock.

Q: How do the 309,467 RSUs granted to Jason R. Kelly at DNA vest over time?

The 309,467 RSUs vest in equal quarterly installments over 12 quarters , with the first vesting date on October 16, 2026 . Each vested RSU converts into one share of Ginkgo Bioworks Class A Common Stock, subject to the award terms.

Q: Who approved the RSU grants to Jason R. Kelly at Ginkgo Bioworks (DNA)?

Both RSU awards to Jason R. Kelly were approved by the Compensation Committee of Ginkgo Bioworks’ Board of Directors on July 28, 2026 . This committee-level approval reflects the company’s standard governance process for executive equity compensation.

Q: What does each Restricted Stock Unit (RSU) represent in the Ginkgo Bioworks (DNA) awards?

Each RSU in these awards represents a contingent right to receive one share of Ginkgo Bioworks’ Class A Common Stock . Shares are only delivered upon vesting, according to the specific schedules tied to each grant.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Kelly Jason R reported acquisition or exercise transactions in this Form 4 filing.

Ginkgo Bioworks Holdings, Inc. granted Chief Executive Officer and founder Jason R. Kelly two awards of restricted stock units on July 28, 2026. One grant covers 74,258 RSUs vesting 75% on October 16, 2026 and 25% on January 21, 2027. The other grant covers 309,467 RSUs vesting in equal quarterly installments over 12 quarters starting October 16, 2026. Each RSU represents a contingent right to receive one share of Class A Common Stock.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Kelly Jason R

Role See remarks

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units ^{F1, F2}	74,258	--	--
Grant/Award	Restricted Stock Units ^{F1, F3}	309,467	--	--

Holdings After Transaction: Restricted Stock Units — 383,725 shares (Direct)

Footnotes (3)

F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2. The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% on October 16, 2026 and 25% on January 21, 2027.
F3. The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters, with the first vesting to occur on October 16, 2026.

Key Figures

RSU grant 1: 74,258 RSUs RSU grant 2: 309,467 RSUs Initial vesting date: October 16, 2026 +2 more

5 metrics

RSU grant 1 74,258 RSUs Restricted Stock Units granted to Jason R. Kelly on July 28, 2026 with front-loaded vesting

RSU grant 2 309,467 RSUs Restricted Stock Units granted to Jason R. Kelly on July 28, 2026 vesting over 12 quarters

Initial vesting date October 16, 2026 First vesting date for both RSU awards

Front-loaded vesting 75% / 25% 75% of 74,258 RSUs vest on October 16, 2026; 25% on January 21, 2027

Vesting duration 12 quarters 309,467 RSUs vest in equal quarterly installments over the next 12 quarters

Key Terms

Restricted Stock Units, Class A Common Stock, Compensation Committee, vesting

4 terms

Restricted Stock Units financial

"Two awards of restricted stock units were granted to Jason R. Kelly"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Class A Common Stock financial

"Each RSU represents a contingent right to receive one share of Class A Common Stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Compensation Committee financial

"The RSUs were approved by the Compensation Committee of the Board of Directors"

A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.

vesting financial

"RSUs shall vest as follows: 75% on October 16, 2026 and 25% on January 21, 2027"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/30/2026 - 04:26 PM Accepted by SEC EDGAR 07/30/2026 - 04:26 PM

FAQ

What insider transactions did Ginkgo Bioworks (DNA) report for Jason R. Kelly on July 28, 2026?

Jason R. Kelly received two grants of Restricted Stock Units on July 28, 2026: one for 74,258 RSUs and another for 309,467 RSUs. Both awards are tied to Ginkgo Bioworks’ Class A Common Stock and follow specified vesting schedules.

What are the vesting terms for the 74,258 RSUs granted at Ginkgo Bioworks (DNA)?

The 74,258 RSUs granted to Jason R. Kelly vest 75% on October 16, 2026 and 25% on January 21, 2027. Once vested, each RSU entitles him to receive one share of Ginkgo Bioworks Class A Common Stock.

How do the 309,467 RSUs granted to Jason R. Kelly at DNA vest over time?

The 309,467 RSUs vest in equal quarterly installments over 12 quarters, with the first vesting date on October 16, 2026. Each vested RSU converts into one share of Ginkgo Bioworks Class A Common Stock, subject to the award terms.

Who approved the RSU grants to Jason R. Kelly at Ginkgo Bioworks (DNA)?

Both RSU awards to Jason R. Kelly were approved by the Compensation Committee of Ginkgo Bioworks’ Board of Directors on July 28, 2026. This committee-level approval reflects the company’s standard governance process for executive equity compensation.

What does each Restricted Stock Unit (RSU) represent in the Ginkgo Bioworks (DNA) awards?

Each RSU in these awards represents a contingent right to receive one share of Ginkgo Bioworks’ Class A Common Stock. Shares are only delivered upon vesting, according to the specific schedules tied to each grant.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kelly Jason R

(Last)

(First)

(Middle)

C/O GINKGO BIOWORKS HOLDINGS

27 DRYDOCK AVENUE

(Street)

BOSTON

MASSACHUSETTS

02210

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ginkgo Bioworks Holdings, Inc. [ DNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	See remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	07/28/2026		A		74,258		⁽²⁾	⁽²⁾	Class A Common Stock	74,258	⁽¹⁾	74,258	D
Restricted Stock Units	⁽¹⁾	07/28/2026		A		309,467		⁽³⁾	⁽³⁾	Class A Common Stock	309,467	⁽¹⁾	309,467	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

2. The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% on October 16, 2026 and 25% on January 21, 2027.

3. The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters, with the first vesting to occur on October 16, 2026.

Remarks:

Chief Executive Officer & Founder

	/s/ Karen Tepichin, Attorney-in-Fact	07/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR